GPT Healthcare Limited (NSE:GPTHEALTH)
India
· Delayed Price · Currency is INR | Market Cap | 12.74B |
| Revenue (ttm) | 4.05B |
| Net Income (ttm) | 498.48M |
| Shares Out | 82.05M |
| EPS (ttm) | 6.10 |
| PE Ratio | 25.46 |
| Forward PE | 20.16 |
| Dividend | 2.50 (1.60%) |
| Ex-Dividend Date | Nov 28, 2024 |
| Volume | 80,032 |
| Average Volume | 110,413 |
| Open | 154.00 |
| Previous Close | 155.23 |
| Day's Range | 154.00 - 157.00 |
| 52-Week Range | 126.10 - 208.45 |
| Beta | n/a |
| RSI | 47.39 |
| Earnings Date | Jun 5, 2025 |
About GPT Healthcare
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the name ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; emergency and critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurosciences; pediatrics; neonatology; robotic procedures; bariatric and metabolic surgery; minimally invasive gyanecological su... [Read more]
Financial Performance
In 2023, GPT Healthcare's revenue was 4.00 billion, an increase of 10.85% compared to the previous year's 3.61 billion. Earnings were 477.69 million, an increase of 22.46%.
Financial StatementsNews
GPT Healthcare commissions 158-bed quaternary care hospital in Raipur, Chhattisgarh
GPT Healthcare Ltd. announced the commissioning of its greenfield quaternary care hospital in Raipur, Chhattisgarh, on Friday, May 2, 2025. Branded under ILS Hospitals, this 158-bedded facility is str...
GPT Healthcare Q2 FY25 Results: Revenue down 2.1% YoY to Rs 108.47 crore, Net Profit falls 10.5% YoY
GPT Healthcare Limited has reported its unaudited financial results for the second quarter of FY25, showcasing steady growth in revenue along with a modest increase in profit. Key Financial Highlights...